Abstract
AA amyloidosis is a systemic disease characterized by deposition of misfolded serum amyloid A protein (SAA) into cross-β amyloid in multiple organs in humans and animals. AA amyloidosis occurs at high SAA serum levels during chronic inflammation. Prion-like transmission was reported as possible cause of extreme AA amyloidosis prevalence in captive animals, e.g. 70% in cheetah and 57–73% in domestic short hair (DSH) cats kept in zoos and shelters, respectively. Herein, we present the 3.3 Å cryo-EM structure of AA amyloid extracted post-mortem from the kidney of a DSH cat with renal failure, deceased in a shelter with extreme disease prevalence. The structure reveals a cross-β architecture assembled from two 76-residue long proto-filaments. Despite >70% sequence homology to mouse and human SAA, the cat SAA variant adopts a distinct amyloid fold. Inclusion of an eight-residue insert unique to feline SAA contributes to increased amyloid stability. The presented feline AA amyloid structure is fully compatible with the 99% identical amino acid sequence of amyloid fragments of captive cheetah.
Similar content being viewed by others
Introduction
Amyloidosis is associated with the deposition of proteinaceous amorphous structures in the extracellular space of tissue and organs in humans and animals1. Amyloids in biopsies are histologically revealed by apple-green birefringence under polarized light after Congo Red staining1,2. Each of more than 50 disease-causing amyloidogenic proteins is associated with a specific disease type and organ distribution1,3,4. Immunohistochemistry and mass spectrometry-based determination of amyloid type is vital for effective treatment2,5,6. Single-particle cryo-EM has recently been applied to classify human brain amyloidoses (tauopathies) based on fibril structures, potentially impacting future diagnosis and treatment of these devastating neurodegenerative diseases7. Specifically, AA amyloidosis represents a systemic disease characterized by the deposition of misfolded serum amyloid A protein (SAA) in multiple organs2,8. This 12–14 kDa remarkably conserved apo-lipoprotein acts as molecular mop to remove membrane debris and lipid degradation products from inflammatory injury sites9,10,11,12. As part of the host innate response to inflammation, acute-phase SAA is secreted by the liver to increase serum levels up to 1000-fold2,9,10,13,14,15. A minor fraction of SAA adopts an α-helical bundle structure that delivers retinol to intestinal myeloid cells, including macrophages, to promote adaptive immunity16,17. The vast majority of SAA with a more disordered and enigmatic structure is bound in high-density lipoprotein (HDL), likely contributing to cholesterol homeostasis in macrophages2,9,15,18,19. Chronic inflammation leads to sustained increased SAA concentrations, to an extent that macrophages reportedly fail to prevent proteolysis-resistant oligomers during lysosomal degradation20,21. Low pH in lysosomes may favor transition of SAA into highly ordered almost indestructible amyloid20,21,22,23. Final assembly into massive AA amyloid deposits physically distorts and damages organs, in human patients often diagnosed as kidney-related glomerular proteinuria2,24,25. A comparison of cryo-electron microscopy (EM) structures of ex vivo AA amyloid from diseased organs of a human patient and an experimental mouse model revealed the characteristic cross-β architecture of amyloid, but distinct structures despite 76% sequence identity26. The two structures were added to a growing amyloid structure database exhibiting more diverse folds than originally anticipated23,27. Proteins of identical sequence may adopt different cross-β structures, that are defined in vitro by test tube conditions and ex vivo by tissue origin and disease type3,7,26,27,28,29,30. While amyloid polymorphs of the same protein are energetically similar, disease-associated amyloids appear more stable than functional reversible amyloid31. Due to the conserved amyloidogenic nature of SAA, domestic animals develop systemic amyloidosis similarly to humans2,32,33. Among domestic short hair (DSH) cats, Siamese and Abyssinian breeds were reported as particularly prone to amyloidosis due to a familial predisposition34,35,36,37,38. Strikingly, the close-to-extinct captive cheetah, from whose lineage DSH cat ancestors split about six million years ago, suffers from an extreme disease prevalence of 70%, reportedly facilitated by prion-like transmission39,40,41. The classical prion disease transmissible spongiform encephalopathies (TSE) is caused by conversion of the native cellular prion protein PrPC into its amyloidogenic PrPsc form, infectious as non-fibrillar ~600 kDa oligomer and larger amyloid fragments42,43,44,45,46. Protein aggregates spreading trans-cellularly through the human nervous system in Alzheimer’s and Parkinson’s disease have been referred to as prionoids, to acknowledge lacking evidence of horizontal transmission47,48,49. Importantly, SAA has been suggested as prion candidate, based on extreme disease prevalence in captive cheetah and experimentally accelerated AA amyloidosis in chronically inflamed animals after intravenous injection or oral administration of amyloid2,48,50,51. Our recent study has revealed a prevalence of 57–73% among 80 domestic short hair (DSH) cats kept in shelters52, in stark contrast to a very low prevalence (1–2%) in client-owned cats53,54. AA amyloid deposits were found in the kidney, liver, spleen, and even the heart52. SAA was present in cat bile, indicating a potential fecal-oral transmission route, as reported for captive cheetah39,52.
Herein, we present the cryo-EM structure of fibrils extracted post-mortem from the diseased kidney of a DSH cat with systemic AA amyloidosis, deceased in a shelter with extreme disease prevalence. The structure exhibits the characteristic cross-β architecture of amyloid, but adopts a unique fold. The amino acid sequence of AA amyloid from a cheetah deceased in a zoo is fully compatible with the presented feline amyloid structure.
Results and discussion
AA amyloid extracted from the kidney of a DSH cat deceased with renal failure
During the last two months of a two-year stay in a shelter in Northern Italy, a female DSH cat became anorectic, developed jaundice and lost significant body weight. She was affected by chronic kidney and liver disease, and had no retroviral infections. Due to worsened renal failure, euthanasia was requested when the cat was six years old. Histology of the kidney revealed mild chronic multifocal interstitial nephritis and that of the liver showed severe diffuse hypotrophy/atrophy of the hepatocytes. Abundant, amorphous and eosinophilic material in the kidney, liver and spleen stained positive for Congo red and appeared green-apple birefringent under polarized light, consistent with amyloid (Fig. 1a and Supplementary Fig. 1a). We suspected AA amyloidosis, representing the most commonly observed type of amyloidosis in animals2,32,33. Antibodies raised against feline SAA-derived peptides co-stained Thioflavin S-positive tissue sections in the kidney, liver and spleen (Supplementary Fig. 1b), as reported previously for 34 additional cats with systemic AA amyloidosis in all three organs52. Peptides obtained from kidney-derived fibril extracts were analyzed by liquid chromatography with tandem mass spectrometry (LC-MS/MS) to identify residue numbers 19–111 of the feline SAA precursor (Q1T770), corresponding to residue numbers 1–93 of the mature protein lacking the signal peptide, as most abundant matches (Supplementary Table 1 and Supplementary Fig. 2). Based on negative stain electron microscopy (EM), revealing straight helical filaments with crossover distances in the 650–700 Å range (Fig. 1b), fibril extraction was optimized for collection of a high-resolution single-particle cryo-EM dataset.
Cat AA amyloid is built from two identical 76-residue long proto-filaments stabilized through staggered ionic lock and hydrophobic cluster interactions
Cryo-electron micrographs of vitrified AA amyloid extracts revealed a homogeneous population of straight fibrils (Fig. 2a) that were manually picked for standard helical reconstruction (Supplementary Fig. 3a)55,56. About 65k from initially 380k segments were refined with C2 symmetry, a left-handed twist angle of 1.3° and a helical rise of 4.9 Å to yield a final map with a nominal resolution of 3.3 Å, as estimated from half-map Fourier shell correlation curves (FSC) (Supplementary Fig. 3b). Reasonable map-model statistics as well as matching 2D class averages and map projections provide evidence of a physically valid model built into a consistently reconstructed map (Fig. 2a–d, Supplementary Fig. 4 and Supplementary Table 2). The fibril structure is composed of two identical proto-filaments, and exhibits the cross-β architecture characteristic of amyloid (Fig. 2). The polypeptide of each proto-filament comprises 11 β-strands between residue positions 19 and 94 and adopts an extended hairpin structure. Residues 95–111, identified by LC-MS/MS as component of the extracted AA amyloid, were not visible in the map. A central β-arch between residues Asp-50 and Arg-64 links two ~25 residue long meandering tails that stick together via side chain contacts. A noteworthy feature following the β-arch is an unusual backbone bulge adopted by the P66GGAW70 segment comprising Pro-66 modeled as cis-isomer (Supplementary Fig. 5a), in contrast to the trans-Proline residues in mouse and human AA amyloid (Supplementary Fig. 5b). To the best of our knowledge, this is the first example of a cis-Proline in amyloid. Isomerization of unfolded SAA may occur spontaneously, as observed in human dialysis-related amyloidosis of β2-microglobulin, but could also be catalyzed by isomerases57,58,59,60,61. In the assembled fibril, the N-terminal tails are surface-exposed at the edges, while the C-terminal tails are buried facing each other (Fig. 2c). Each polypeptide deviates from planarity traversing more than three rung layers (Fig. 2e). While the β-arch lies almost perpendicular to the fibril axis, the exposed edge- and buried face-tails are tilted by 15° and 10°, respectively. At the intra-protomer interface (Fig. 3 and Supplementary Fig. 6), the edge-tail of rung layer (i) contacts the face-tails (i-1) to (i + 2), creating four hydrophobic clusters, four ionic locks and additional H-bond interactions. On the other side, at the inter-protomer interface (Fig. 3 and Supplementary Fig. 6), the face-tail (i) contacts four rung layers of the adjacent proto-filament, creating two hydrophobic clusters, four ionic locks and two additional H-bond interactions. Such staggered interactions contribute to fibril stability, as described previously27.
The distinct fold of cat AA amyloid buries its unique eight-residue insert between the two proto-filaments
Although the amino acid sequences of the published human and mouse AA amyloid structures26 are >70% identical to the cat structure, each fold is distinct (Fig. 4). Compared to the 54-residue short core of human AA amyloid, the mouse and cat structures are elongated by 14 and 22 residues, respectively. Each structure adopts a unique fold, exhibiting distinct arrangements of β-strands that vary slightly in number and lengths, despite high sequence identities (Fig. 4a). In each fibril, different parts of the sequences are exposed or buried. In cat AA amyloid, residues 19–49 comprising strands β1-β4 are exposed as part of the edge-tail, comprising two short segments that are partially buried in sharp turns. Longer buried segments are observed for the corresponding region in both human and mouse AA amyloid, but with different distributions. Despite these differences, a segment between residues 24 and 54 of human AA amyloid superposes well on the cat structure with a rmsd-value of 2.5 Å (Supplementary Fig. 7). The concomitant observation of shared and distinct structural elements in sequence-homologous amyloid has been referred to as type-2 polymorphism27. The surface-exposed β-arch of cat AA amyloid, comprising residues 50 to 64, adopts more extended conformations in the two other structures. In human AA amyloid, residues 50–55 are buried, followed by an exposed C-terminal segment. In mouse AA amyloid, residues 50–64 are exposed, while residues 65–86 adopt a U-shaped structure that is, except for residues 66–72, largely exposed and in loose contact with the other protomer. A non-conserved sequence insertion at position 86 of the precursor protein sequence sets apart the cat from mouse and human SAA variants10. In the cat fibril, the insert constitutes a part of the buried tail at the inter-protomer interface.
Inclusion of the eight-residue insert in cat AA amyloid increases mass, buried surface area and stability of fibril core
The described differences of the protein sequences and amyloid folds yield unique fibril architectures (Fig. 4, Supplementary Figs. 8 and 9). Structure-based solvation free energy (ΔGsol) calculations31 reveal an estimated stability of −42 kcal/mol for a single cat AA amyloid molecule, similarly to mouse, but 5–10 kcal/mol more stable than human AA amyloid (Supplementary Fig. 10a). Typically, ΔGsol-values of disease-related amyloids range between −25 and −62 kcal/mole31. As an alternative estimate of fibril stability, we calculated the dissociation energy cost (ΔGdiss)62 of a single molecule from its respective fibril end (Supplementary Fig. 10b), which is about 4 and 8 kcal/mole higher for cat relative to mouse and human AA amyloid, respectively. The higher dissociation cost is mainly caused by the eight-residue insert that increases fibril core mass and enlarges the buried surface area by ~2000 Å2. Additionally, the insert might destabilize feline native SAA (Supplementary Fig. 11) to increase levels of misfolded SAA available for fibrillation.
Remarkably, the amino acid sequence of AA amyloid extracted post-mortem from the diseased liver of the distantly related captive cheetah is 99% identical to the sequence of the extracted cat fibril, also comprising the eight-residue insert (Fig. 5). While cheetah AA amyloid may adopt an identical or a distinct fold, we consider the only N93S substitution in cheetah fully compatible with the herein presented structure. Captive cheetah in zoos suffer from a similarly high AA-amyloidosis prevalence of 70%, reportedly facilitated by a prion-like disease transmission39,40,51. Whether auto-catalytic, self-perpetuating and self-propagating amyloids are defined as prions, depends primarily on their capacity to undergo the full transmission cycle of an infective agent44,45,63. AA amyloid extracted from the liver and feces of cheetah was demonstrated to infect inflamed mice with elevated SAA precursor levels39. We may speculate that higher mass and increased structural stability of AA amyloid, as reported here for the feline variant, could increase its environmental persistence and resistance to clearance in the host. If fecal-oral transmission becomes accessible in crowded populations of chronically inflamed felids, prion-like disease outbreaks might be recognized by extreme prevalence as reported for cat and cheetah in shelters and zoos39,40,51,52.
In summary, here we report the 3.3 Å cryo-EM structure of feline fibrils associated with extreme AA amyloidosis prevalence in a cat shelter. The structure is unique in representing the first ex vivo structure of a spontaneously occurring amyloid obtained from an animal kept in a man-made habitat. Remarkably, amyloid extracted from captive cheetah with reported prion-like transmission is almost identical in sequence. Inclusion of the eight-residue insert unique to feline AA amyloid increases mass and stability of its fibril core, which could facilitate fecal-oral transmission.
Methods
Diagnosis of AA amyloidosis
Cats and clinical data
Amyloid was extracted from cat AAG17 which had been enrolled prospectively together with 79 other cats for our related study52. All animals were handled according to protocols approved by the Swiss Federal Veterinary Office (Application #30369). Kidney-derived fibril extracts were obtained from a sterilized female DSH cat with ID code AF755, which was euthanized at 6 years of age. The sterilized female DSH cat AG573 and castrated male DSH cat AI264, whose staining images are shown as controls (Supplementary Fig. 1c), was euthanized at 15 years of age and died at 8 years of age, respectively.
Histology and immunofluorescence
Full details were described previously52. In brief, organs were collected within 5 h from death, fixed in 10% formalin, and embedded in paraffin. After automatic sectioning, 4–5 µm-thick slices were stained with hematoxylin/eosin and Congo red and examined using standard and polarized light microscopy. After deparaffinization, amyloids and nuclei were stained with 1% (w/V) Thioflavine S and DAPI, respectively. For immunofluorescence, serum was obtained by immunization of Balb/c mice with peptide-conjugated virus-like particle (VLPs), as previously described in detail52,64. Residues 41–50 (MREANYIGAD), 63–74 (QRGPGGAWAAKV) and 109–122 (EWGRSGKDPNHFRP) of Uniprot entry P19707 were selected as antigens. Serum specificity was assessed using ELISA. Tissue was stained using serum, goat anti-mouse monoclonal IgG conjugated to biotin (1030-08, SouthernBiotech, Birmingham, Alabama) and streptavidin conjugated to Alexa-546 (s11225, Molecular Probes, Eugene, OR, USA) at 1:10, 1:500 and 1:500 dilutions, respectively. Images were acquired with AxioImager A2 and AxioCam (Carl Zeiss, Jena, Germany).
Fibril extraction
After excision, non-fixed cat kidneys were stored frozen (−80 °C) until amyloids were extracted as described previously65,66,67. Briefly, 0.5 g of kidney tissue (from the pole region) were minced with a scalpel and washed in Tris calcium buffer (20 mM Tris, 140 mM NaCl, 2 mM CaCl2, pH 8.0). The tissue was digested with 5 mg Clostridium histolyticum collagenase (Sigma Aldrich, Saint Louis, MO, USA) dissolved in 1 ml of Tris calcium buffer, followed by 10 cycles of homogenization in Tris EDTA buffer (1 ml, 20 mM Tris, 140 mM NaCl, 10 mM EDTA, pH 8.0). Supernatants were discarded after each homogenization step. The remaining pellet was then repeatedly homogenized in 0.5 ml ice-cold water, storing supernatants. Water extracts were analyzed by SDS-PAGE under denaturing and reducing conditions. The cryo-EM and proteomic analyses were performed on water extract #2 (Supplementary Fig. 2a). Fibril proteins were solubilized for 1 h at room temperature in 8 M urea/0.1 M DTT, and quantified using BioRad Protein assay (Bio-Rad, Hercules, CA, USA.
LC-MS/MS
30 μg of solubilized and reduced protein was alkylated (150 mM iodoacetamide, 1 h, RT, dark), diluted with 100 mM NH4HCO3/5% acetonitrile (V/V) to a final urea concentration of 1.3 M, and digested with Trypsin (Sequence grade, Promega, Madison, WI, USA) at a 1:20 (w/w) ratio for 16 h at 37 °C. Peptides were purified using Pierce C18 Tips (Thermo Fisher Scientific) and analyzed by LC-MS/MS (Supplementary Table 1). Uniprot entries Q1T770, Q9XSG7, A0A337SKP2 and Q5XXU5, were identified as top hits from the Felis catus proteome.
Structure of AA amyloid by single-particle cryo-EM
Sample preparation and data collection
A 4-μl droplet of fibrils sample was applied onto a C-flat thick 1.2/1.3 300 mesh Cu, previously glow-discharged for 30 s at 30 mA using a GloQube system (Quorum Technologies). The sample was blotted immediately and plunge-frozen in liquid ethane using a Vitrobot Mk IV (Thermo Fischer Scientific). A cryo-EM dataset of 2,652 movies was collected automatically on a Talos Arctica 200 kV (Thermo Fisher Scientific), equipped with a Falcon 3 direct electron detector operated in electron counting mode (Supplementary Table 2).
Helical reconstruction
Fibrils were picked manually from dose-weighted, motion- and CTF-corrected image micrographs in RELION 3.155,56,68,69. After manual picking, a first set of 65,131 segments were extracted in 1000-pixel boxes binned by 4 and a 10% inter-box distance. The tube diameter, rise and number of asymmetrical units were set to 125 Å, 4.75 Å and 21, respectively. Reference-free 2D classification was performed to select a single large class average for initial model generation with an estimated crossover distance of 700 Å. A second set of 381,233 smaller segments was extracted for the refinement applying a box size of 250 pixel with 10% inter-box distance and helical tube diameter, rise and asymmetrical unit values of 150 Å, 4.75 Å and 5, respectively. The initial model was re-scaled and re-windowed to match the un-binned particles and low-pass-filtered to 10 Å. 3D auto-refinement applying C1 symmetry, angular sampling, helical twist and rise values of 3.7°, 1.3° and 4.75 Å, respectively, yielded an ~4 Å resolution map. Imposing apparent C2 symmetry improved map resolution to 3.8 Å. Three out of four 3D classes summed up to 335,024 particles with similar cross-section densities. After additional steps comprising 3D class average selection, Bayesian polishing, CTF refinement and mask-generation, 65,122 particles were aligned by the final 3D auto-refinement with solvent-flattened FSC for map reconstruction. The final map was reconstructed with helical twist and rise values of 1.3° and 4.9 Å to an estimated resolution of 3.3 Å.
Model building
After map auto-sharpening in Phenix70, the model was built de novo starting from a map region featuring an unusual backbone bulge with an associated bulky side-chain volume. The bulge was identified as P66GGAW70 in the LC-MS/MS-identified amino acid sequence. The model was built and refined in Coot, Chimera-Isolde as well as Phenix real-space refinement initially with and later without Amber gradients71,72,73,74,75. Molprobity validation76 revealed model issues that were resolved by rebuilding of a single chain into the inverted map with left-handed twist. Five 76-residue long chains in each proto-filament were modeled and refined with non-crystallographic symmetry (NCS) restraints. In the final stages of refinement, we modeled Proline-66 as cis-isomer to fit the backbone carbonyl into the map, although a higher resolution is required to discriminate conclusively between cis- and trans-Proline. We also note additional densities close to residues Gly-65 and Ser-82, which may be occupied by ions or organic compounds of unknown origin. Phenix, Molprobity and EMDB validation76,77,78 revealed map-model cross-correlation (CCmask), EM-ringer and Molprobity-score values of 0.74, 5.1 and 1.4, indicative of a physically valid model with definite map support.
Data analysis and visualization
Structures and derived data were analyzed and visualized using PyMol (Schrödinger, NY, USA) and Rstudio79,80,81,82,83. Molecular contact fingerprints, flexible structural alignments and buried surface areas as well as dissociation free energies of assemblies (ΔGdiss) were obtained from Arpeggio, FATCAT and PISA webservers84,85,86. Solvation free energies (ΔGsol) were calculated in R following published procedures, using atomic solvent-accessible surface areas and H-bonds obtained by freeSASA and Arpeggio, respectively31,85,87,88,89. Sequences were aligned and visualized using Uniprot, Blast, ClustalOmega, ESPript and Jalview90,91,92,93,94.
Statistics and reproducibility
Histology and immunofluorescence staining protocols were optimized to stain tissue samples of 80 cats, as described previously52. Optimized protocols allowed us to obtain the images shown in Fig. 1 and Supplementary Fig. 1 at first trial (n = 1). The negative stain shown in Fig. 1b was selected from a collection of 13 micrographs comprising amyloid fibrils at different concentrations. The micrograph excerpt shown in Fig. 2a represents a single, straight amyloid selected from 15510 manually picked particles in 2652 micrographs (Supplementary Table 2). A selection of micrographs with variable amyloid particle distributions is shown in Supplementary Fig. 3a. LC-MS/MS data were collected four times on the same extract to optimize acquisition parameters for the final dataset (n = 1) (Supplementary Table 1).
Data availability
The LC-MS/MS data have been deposited to the ProteomeXchange Consortium via the PRIDE95 partner repository with the dataset id PXD035851. Cryo EM associated data have been deposited with id codes EMPIAR-11001, EMD-14726 and 7ZH7 at the EMPIAR, EMDB and RCSB data banks, respectively77,96,97. Other structures referenced in the manuscript are publicly available under the PDB accession codes, 4IP8, 6MST, 6DSO and 7ZH7. Raw histological and IF staining images are available on request to the corresponding author.
References
Benson, M. D. et al. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 27, 217–222 (2020).
Westermark, G. T., Fändrich, M. & Westermark, P. AA amyloidosis: pathogenesis and targeted therapy. Annu. Rev. Pathol. 10, 321–344 (2015).
Fändrich, M. et al. Amyloid fibril polymorphism: a challenge for molecular imaging and therapy. J. Intern. Med. 283, 218–237 (2018).
Iadanza, M. G., Jackson, M. P., Hewitt, E. W., Ranson, N. A. & Radford, S. E. A new era for understanding amyloid structures and disease. Nat. Rev. Mol. Cell. Biol. 19, 755–773 (2018).
Dasari, S. et al. Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples. Mayo Clin. Proc. 95, 1852–1864 (2020).
Nevone, A., Merlini, G. & Nuvolone, M. Treating protein misfolding diseases: therapeutic successes against systemic amyloidoses. Front. Pharmacol. 11, 1024 (2020).
Shi, Y. et al. Structure-based classification of tauopathies. Nature 598, 359–363 (2021).
Westermark, G. T. & Westermark, P. Serum amyloid A and protein AA: Molecular mechanisms of a transmissible amyloidosis. FEBS Lett. 583, 2685–2690 (2009).
Sack, G. H. Serum amyloid A – a review. Mol. Med. 24, 46 (2018).
Uhlar, C. M. & Whitehead, A. S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265, 501–523 (1999).
Frame, N. M., Jayaraman, S., Gantz, D. L. & Gursky, O. Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a ‘molecular mop’ in immune response. J. Struct. Biol. 200, 293–302 (2017).
Jayaraman, S., Fändrich, M. & Gursky, O. Synergy between serum amyloid A and secretory phospholipase A2. eLife 8, e46630 (2019).
Kushner, I. The phenomenon of the acute phase response*. Ann. N. Y. Acad. Sci. 389, 39–48 (1982).
Ye, R. D. & Sun, L. Emerging functions of serum amyloid A in inflammation. J. Leukoc. Biol. 98, 923–929 (2015).
Kisilevsky, R. & Manley, P. N. Acute-phase serum amyloid A: Perspectives on its physiological and pathological roles. Amyloid 19, 5–14 (2012).
Hu, Z., Bang, Y.-J., Ruhn, K. A. & Hooper, L. V. Molecular basis for retinol binding by serum amyloid A during infection. Proc. Natl Acad. Sci. USA 116, 19077–19082 (2019).
Bang, Y.-J. et al. Serum amyloid A delivers retinol to intestinal myeloid cells to promote adaptive immunity. Science 373, eabf9232 (2021).
White, R., Giordano, S. & Datta, G. Role of HDL-associated proteins and lipids in the regulation of inflammation. In: Advances in lipoprotein research (IntechOpen, 2017). https://doi.org/10.5772/67141.
Frame, N. M. & Gursky, O. Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks. FEBS Lett. 590, 866–879 (2016).
Jayaraman, S., Gantz, D. L., Haupt, C. & Gursky, O. Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis. Proc. Natl Acad. Sci. USA 114, E6507–E6515 (2017).
Claus, S. et al. Cellular mechanism of fibril formation from serum amyloid A1 protein. EMBO Rep. 18, 1352–1366 (2017).
Dobson, C. M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24, 329–332 (1999).
Ke, P. C. et al. Half a century of amyloids: past, present and future. Chem. Soc. Rev. 49, 5473–5509 (2020).
Obici, L. & Merlini, G. AA amyloidosis: basic knowledge, unmet needs and future treatments. Swiss Med. Wkly. 142, w13580 (2012).
Kollmer, M. et al. Electron tomography reveals the fibril structure and lipid interactions in amyloid deposits. Proc. Natl Acad. Sci. USA 113, 5604–5609 (2016).
Liberta, F. et al. Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids. Nat. Commun. 10, 1104 (2019).
Gallardo, R., Ranson, N. A. & Radford, S. E. Amyloid structures: much more than just a cross-beta fold. Curr. Opin. Struct. Biol. 60, 7–16 (2020).
Yang, Y. et al. Cryo-EM structures of amyloid-β 42 filaments from human brains. Science 375, 167–172 (2022).
Bansal, A. et al. AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils. Nat. Commun. 12, 1013 (2021).
Lövestam, S. et al. Assembly of recombinant tau into filaments identical to those of Alzheimer’s disease and chronic traumatic encephalopathy. eLife 11, e76494 (2022).
Sawaya, M. R., Hughes, M. P., Rodriguez, J. A., Riek, R. & Eisenberg, D. S. The expanding amyloid family: Structure, stability, function, and pathogenesis. Cell 184, 4857–4873 (2021).
Woldemeskel, M. A concise review of amyloidosis in animals. Vet. Med. Int. 2012, 427296 (2012).
Murakami, T., Ishiguro, N. & Higuchi, K. Transmission of systemic AA amyloidosis in animals. Vet. Pathol. 51, 363–371 (2014).
Niewold, T. A., van der Linde-Sipman, J. S., Murphy, C., Tooten, P. C. & Gruys, E. Familial amyloidosis in cats: Siamese and Abyssinian AA proteins differ in primary sequence and pattern of deposition. Amyloid 6, 205–209 (1999).
van der Linde-Sipman, J. S., Niewold, T. A., Tooten, P. C., de Neijs-Backer, M. & Gruys, E. Generalized AA-amyloidosis in Siamese and Oriental cats. Vet. Immunol. Immunopathol. 56, 1–10 (1997).
Genova, F. et al. Multi-omic analyses in Abyssinian cats with primary renal amyloid deposits. Sci. Rep. 11, 8339 (2021).
Pesavento, P. A. & Murphy, B. G. Common and emerging infectious diseases in the animal shelter. Vet. Pathol. 51, 478–491 (2014).
Paltrinieri, S., Sironi, G., Giori, L., Faverzani, S. & Longeri, M. Changes in serum and urine SAA concentrations and qualitative and quantitative proteinuria in abyssinian cats with familial amyloidosis: a five-year longitudinal study (2009–2014). J. Intern. Med. 29, 505–512 (2015).
Zhang, B. et al. Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc. Natl Acad. Sci. USA 105, 7263–7268 (2008).
Papendick, R. E., Munson, L., O’Brien, T. D. & Johnson, K. H. Systemic AA amyloidosis in captive cheetahs (Acinonyx jubatus). Vet. Pathol. 34, 549–556 (1997).
O’Brien, S. J. et al. State of cat genomics. Trends Genet 24, 268–279 (2008).
Kraus, A. et al. High-resolution structure and strain comparison of infectious mammalian prions. Mol. Cell 81, 4540–4551.e6 (2021).
Soto, C., Estrada, L. & Castilla, J. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem. Sci. 31, 150–155 (2006).
Aguzzi, A. & Calella, A. M. Prions: protein aggregation and infectious diseases. Physiol. Rev. 89, 1105–1152 (2009).
Pritzkow, S., Gorski, D., Ramirez, F. & Soto, C. Prion dissemination through the environment and medical practices: facts and risks for human health. Clin. Microbiol. Rev. 34, e0005919 (2021).
Silveira, J. R. et al. The most infectious prion protein particles. Nature 437, 257–261 (2005).
Goedert, M. Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein. Science 349, 1255555 (2015).
Aguzzi, A. Beyond the prion principle. Nature 459, 924–925 (2009).
Aguzzi, A., Lakkaraju, A. K. K. & Frontzek, K. Toward therapy of human prion diseases. Annu. Rev. Pharmacol. Toxicol. 58, 331–351 (2018).
Sørby, R., Espenes, A., Landsverk, T. & Westermark, G. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Amyloid 15, 20–28 (2008).
Lundmark, K. et al. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl Acad. Sci. U. S. A. 99, 6979–6984 (2002).
Ferri, F. et al. AA-amyloidosis in cats (Felis catus) housed in shelters. Preprint at https://www.biorxiv.org/content/10.1101/2022.05.04.490646v1 (2022).
Rossi, F. et al. Immune-complex glomerulonephritis in cats: a retrospective study based on clinico-pathological data, histopathology and ultrastructural features. BMC Vet. Res. 15, 303 (2019).
Zini, E., Hauser, B., Meli, M. L. & Glaus, T. M. Transient laboratory changes in a cat with repeated hepatic haemorrhages due to amyloidosis. Vet. Rec. 162, 24–26 (2008).
He, S. & Scheres, S. H. W. Helical reconstruction in RELION. J. Struct. Biol. 198, 163–176 (2017).
Scheres, S. H. W. Amyloid structure determination in RELION-3.1. Acta Crystallogr. D. 76, 94–101 (2020).
Lin, W. et al. Peptidyl prolyl cis/trans isomerase activity on the cell surface correlates with extracellular matrix development. Commun. Biol. 2, 1–11 (2019).
Wedemeyer, W. J., Welker, E. & Scheraga, H. A. Proline cis−trans isomerization and protein folding. Biochemistry 41, 14637–14644 (2002).
Jahn, T. R., Parker, M. J., Homans, S. W. & Radford, S. E. Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat. Struct. Mol. Biol. 13, 195–201 (2006).
Verdone, G. et al. The solution structure of human β2-microglobulin reveals the prodromes of its amyloid transition. Protein Sci. 11, 487–499 (2002).
Eichner, T. & Radford, S. E. A generic mechanism of β2-microglobulin amyloid assembly at neutral pH involving a specific proline switch. J. Mol. Biol. 386, 1312–1326 (2009).
Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797 (2007).
Willbold, D., Strodel, B., Schröder, G. F., Hoyer, W. & Heise, H. Amyloid-type protein aggregation and prion-like properties of amyloids. Chem. Rev. 121, 8285–8307 (2021).
Storni, F. et al. Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens. J. Allergy Clin. Immunol. 145, 1240–1253.e3 (2020).
Swuec, P. et al. Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient. Nat. Commun. 10, 1269 (2019).
Lavatelli, F. et al. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol. Cell Proteom. 7, 1570–1583 (2008).
Lavatelli, F. et al. Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis. J. Biol. Chem. 295, 16572–16584 (2020).
Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216–221 (2015).
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
Terwilliger, T. C., Sobolev, O. V., Afonine, P. V. & Adams, P. D. Automated map sharpening by maximization of detail and connectivity. Acta Crystallogr. D. 74, 545–559 (2018).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. 60, 2126–2132 (2004).
Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D. 74, 519–530 (2018).
Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D. 74, 531–544 (2018).
Moriarty, N. W. et al. Improved chemistry restraints for crystallographic refinement by integrating the Amber force field into Phenix. Acta Crystallogr. D. 76, 51–62 (2020).
Davis, I. W. et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375–W383 (2007).
Lawson, C. L. et al. EMDataBank unified data resource for 3DEM. Nucleic Acids Res. 44, D396–D403 (2016).
Afonine, P. V. et al. New tools for the analysis and validation of cryo-EM maps and atomic models. Acta Crystallogr. D. 74, 814–840 (2018).
Wickham, H. ggplot2: elegant graphics for data analysis (Springer International Publishing, 2016).
Wickham, H. et al. Welcome to the tidyverse. J. Open Source Softw. 4, 1686 (2019).
R Core Team. R: A language and environment for statistical computing (R Core Team, 2020).
Hagemans, D., van Belzen, I. A. E. M., Morán Luengo, T. & Rüdiger, S. G. D. A script to highlight hydrophobicity and charge on protein surfaces. Front. Mol. Biosci. 2, 56 (2015).
Grant, B. J., Skjærven, L. & Yao, X.-Q. The Bio3D packages for structural bioinformatics. Protein Sci. 30, 20–30 (2021).
Krissinel, E. Macromolecular complexes in crystals and solutions. Acta Crystallogr. D. 67, 376–385 (2011).
Jubb, H. C. et al. Arpeggio: a web server for calculating and visualising interatomic interactions in protein structures. J. Mol. Biol. 429, 365–371 (2017).
Li, Z., Jaroszewski, L., Iyer, M., Sedova, M. & Godzik, A. FATCAT 2.0: towards a better understanding of the structural diversity of proteins. Nucleic Acids Res. 48, W60–W64 (2020).
Eisenberg, D., Wesson, M. & Yamashita, M. Interpretation of protein folding and binding with atomic solvation parameters. Chem. Scr. 29, 217–222 (1989).
Koehl, P. & Delarue, M. Application of a self-consistent mean field theory to predict protein side-chains conformation and estimate their conformational entropy. J. Mol. Biol. 239, 249–275 (1994).
Mitternacht, S. FreeSASA: An open source C library for solvent accessible surface area calculations. F1000Res. 5, 189 (2016).
The UniProt Consortium. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 49, D480–D489 (2021).
Gouet, P., Courcelle, E., Stuart, D. I. & Métoz, F. ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15, 305–308 (1999).
Madden, T. L., Tatusov, R. L. & Zhang, J. Applications of network BLAST server. Meth. Enzymol. 266, 131–141 (1996).
Chenna, R. et al. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31, 3497–3500 (2003).
Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M. & Barton, G. J. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189–1191 (2009).
Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543–D552 (2022).
Iudin, A., Korir, P. K., Salavert-Torres, J., Kleywegt, G. J. & Patwardhan, A. EMPIAR: a public archive for raw electron microscopy image data. Nat. Methods 13, 387–388 (2016).
Burley, S. K. et al. RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res. 49, D437–D451 (2021).
Berman, H. M. et al. The Protein Data Bank. Nucleic Acids Res. 28, 235–242 (2000).
Acknowledgements
This study was partially supported by Ricerca Corrente funding from Italian Ministry of Health to IRCCS Policlinico San Donato; by Centro di Ricerca Pediatrica, Fondazione Romeo and Enrica Invernizzi (Milan, Italy); Fondazione ARISLA (project TDP- 43-STRUCT); Italian Ministry of Research PRIN 2020 (20207XLJB2); AniCura Clinical Research Grant 2021. We acknowledge excellent support by Valter Fiore (Associazione La Cincia, Val Della Torre, Torino, Italy).
Author information
Authors and Affiliations
Contributions
Conceptualization and Supervision by A.C.S., F.L., M.B., E.Z., and S.R. Investigation and Analysis by A.C.S., T.S., G.Ma., V.S., F.L., F.F., C.P., M.M., P.M., M.N., and A.C.V. Funding acquisition and Resources by G.P., G.Me., M.B., S.F., E.Z., M.V. and S.R. Original draft by T.S. and S.R. Review and Editing by A.C.S., M.B., S.F. and E.Z. Data visualization by T.S., edited and reviewed by A.C.S., S.F. and S.R. Contribution to and approval of the submitted version by all authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Communications thanks Olga Gursky, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Schulte, T., Chaves-Sanjuan, A., Mazzini, G. et al. Cryo-EM structure of ex vivo fibrils associated with extreme AA amyloidosis prevalence in a cat shelter. Nat Commun 13, 7041 (2022). https://doi.org/10.1038/s41467-022-34743-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41467-022-34743-2
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.